Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Asia
Pharma
Astellas, Mitsubishi Tanabe, Leqembi—Fierce Pharma Asia
Astellas reprioritizes its investment focus. Bain buys Mitsubishi Tanabe for $3.3 billion. Eisai sees an upcoming Leqembi "expansion phase." And more.
Angus Liu
Feb 14, 2025 9:51am
Astellas shifts investment focus to later-stage programs: exec
Feb 12, 2025 1:30pm
Merck, AstraZeneca, Astellas—Fierce Pharma Asia
Feb 7, 2025 9:00am
AstraZeneca logs China sales decline in Q4 amid probes
Feb 6, 2025 10:31am
Takeda, Enhertu, East Asian American execs—Fierce Pharma Asia
Jan 31, 2025 8:53am
Takeda, AZ-Daiichi, Fosun-Henlius—Fierce Pharma Asia
Jan 24, 2025 8:55am